NCT00549263View on ClinicalTrials.gov

Bioequivalence Study of SB797620 in Healthy Japanese Volunteers

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2008

Conditions
Healthy Subjects
Interventions
DRUG

SB797620

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY